Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases
NCT06545630 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2024-08-09
Summary
The aim of this study is to explore the safety and efficacy of tumor antigen-sensitized DC vaccine in postoperative adjuvant treatment of R0 excision Colorectal Cancer Liver Metastases.
Conditions
- Carcinoma
- Colorectal Cancer
Interventions
- BIOLOGICAL
-
Tumor antigen-sensitized DC vaccine
subcutaneous administration
Sponsors & Collaborators
-
West China Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-11-01
- Primary Completion
- 2025-11-30
- Completion
- 2026-05-31
Countries
- China
Study Locations
More Related Trials
-
Mix Vaccine for Metastatic Colorectal Cancer
NCT03357276 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Exploratory Study of Sequential Transarterial Chemoembolization With Lipiodol and Neoadjuvant Chemotherapy in the Treatment of Initial Unresectable Colorectal Cancer (CRC)
NCT05340231 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer
NCT05248048 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
NCT04525326 ·Status: UNKNOWN ·Phase: PHASE3
-
Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
NCT03135652 ·Status: WITHDRAWN ·Phase: PHASE2
-
Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
NCT02502630 ·Status: COMPLETED ·Phase: NA
-
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
NCT03022734 ·Status: UNKNOWN ·Phase: PHASE2
-
Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer
NCT06653010 ·Status: SUSPENDED ·Phase: EARLY_PHASE1
-
Laparoscopic Assisted Transanal Total Mesorectal Excision for Rectal Cancer in Low Site
NCT03253302 ·Status: UNKNOWN
-
Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer
NCT00874406 ·Status: UNKNOWN ·Phase: PHASE4
-
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
NCT04755907 ·Status: UNKNOWN
-
Efficacy and Safety Study of Neoadjuvant in Treating Patients With Resectable Local Recurrent Rectal Cancer
NCT01271192 ·Status: UNKNOWN ·Phase: NA
-
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751914 ·Status: RECRUITING ·Phase: NA
-
Research on Surgery and Micro-Invasive Treatment in Recurrent Primary Liver Cancer
NCT00822562 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer
NCT00780988 ·Status: WITHDRAWN ·Phase: PHASE1
-
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
NCT01923987 ·Status: UNKNOWN ·Phase: PHASE2
-
Preserving Left Colonic Artery During Radical Resection of Rectal Cancer
NCT03776370 ·Status: COMPLETED
-
The Evaluation of the Safety and the Efficacy of Transanal Total Mesorectal Excision
NCT01938027 ·Status: COMPLETED ·Phase: NA
-
Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver
NCT00030563 ·Status: COMPLETED ·Phase: PHASE2
-
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NCT06751966 ·Status: RECRUITING ·Phase: NA
-
Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
NCT05353582 ·Status: UNKNOWN ·Phase: PHASE2
-
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
NCT05815082 ·Status: RECRUITING ·Phase: PHASE3
-
Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases
NCT01643070 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase I/II Study of Active Immunotherapy With Cancer Stem Cells Vaccine for Colorectal Cancer
NCT02176746 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of the Efficacy and Safety of Bevacizumab Combined With PD-1 Monoclonal Antibody in Preoperative Neoadjuvant Therapy for MSS Colorectal Cancer With Liver Metastases
NCT06124729 ·Status: NOT_YET_RECRUITING